Wild-type, atg1Δ and genomically tagged Atg2-HTB and Atg9-HTB cells were grown to mid log phase. Cell extracts were prepared by TCA and analysed by anti-Atg1 and anti-Ape1 Western blotting. Blots shown in one panel are from the same blot with the same exposure. (c) atg1Δ strains containing Atg1-HTB and Atg1-D211A-HTB yeast cells were grown to mid log phase and treated with rapamycin for 45 minutes. Atg1 was affinity purified and subjected to quantitative mass spectrometric phosphorylation mapping by SILAC (13C/heavy wild-type vs. 12C/light D211A). Atg1 dependent sites are indicated in red (d) Alignment of Atg1's autophosphorylation sites S517, S356 and S390 as described in Fig. 1f . (e) Wild-type and atg1Δ yeast cells containing endogenously tagged Atg2-HTBeaq were grown to mid log phase and rapamycin treated for 45 minutes. Atg2 was affinity purified and subjected to quantitative mass spectrometric phosphorylation mapping by SILAC (13C/heavy wildtype vs. 12C/light atg1Δ). Atg1 dependent sites are indicated in red. (f) Alignment of Atg2's phosphorylation sites S249 and S1086 as described in Fig. 1f . (g) Atg9-GFP atg2Δ yeast cells containing Atg2-TAP wild-type, S249A S1086A or S249D S1086D double mutants or empty plasmid were grown to mid log phase. Cell extracts were prepared by TCA and analysed by anti-Ape1 Western blotting. Blots shown in one panel are from the same blot with the same exposure. Fig. 1f . (c) GFP-tagged wild-type (wt) Atg9, the Atg9 3A (S657A, S831A, S948A) and the single and double mutants thereof expressed from a centromeric plasmid in atg9Δ cells were grown to mid log phase. Processing of endogenous Ape1 was analysed by Western blotting. (d) Exponentially growing wild-type (control), Atg9-TAP, Atg9-6A-TAP or Atg9-6D-TAP cells were treated for 2h with rapamycin. Cells were then lysed and the extract (T) separated into a cytoplasmic (S13) and a 13'000x g membrane (P13) fraction. The fractions were analysed by Western blotting with anti-PAP (Atg9), anti-Pgk1 (cytoplasmic control) and anti-Pex30 (membrane control) antibodies. (e) Atg9-TAP wildtype, 6A, 6D mutant or atg9Δ cells containing GFP-Atg8 were starved for 4 hours. TCA samples were collected and subjected to anti-GFP Western blotting. (f) Atg9-myc wildtype or the 6A mutant cells were treated with rapamycin and converted to spheroplasts. Total cell extracts from lysed spheroplasts were centrifuged and the pellet fraction was either not treated, or mixed with proteinase K (protK) and/or Triton X-100 (TX100). After protein precipitation, samples were analyzed by Western blotting with anti-Ape1 antibodies. Note that in Fig. 3c the same experiment is shown in a ypt7Δ background. ypt7Δ abolishes the fusion of autophagosomes with the vacuole to prevent Ape1 processing by vacuolar enzymes, allowing an easier comparison of autophagy mutants to wild-type cells. (a) Trafficking of Atg9-GFP was analyzed in wild-type, atg1Δ, Atg1-D211A and Atg1-V432A/E433A cells after starvation. Cells contained Ape1-mCherry to mark the PAS. PAS accumulation is marked with an arrow. Scale bar: 7.5 μm. (b) Trafficking of Atg9-GFP wild-type and the 6A mutant was analysed in wild-type and atg1Δ cells after 30 minutes of rapamycin treatment. Cells contained Ape1-mCherry to mark the PAS. Scale bar: 5 μm. (c) Atg18-GFP atg1Δ cells containing Atg1 wild-type, Atg1-D211A or atg1Δ were analyzed for puncta formation as described in Fig. 4d . All values have been normalized to wild-type. Error bars: standard deviation. (d) Atg9-GFP atg18Δ atg1Δ or atg18Δ atg9Δ cells containing Atg18-TAP or an empty plasmid and Atg1 wild-type or Atg1-D211A were grown to logarithmic phase and treated with rapamycin for 1h. Atg18 was immunoprecipitated and its association with Atg9 was analyzed by anti-GFP immunoblotting. Panels shown are from the same blot with the same exposure. (e) Endogenously tagged Atg9-TAP wild-type (wt), 6A, 6D, atg9Δ or atg12Δ cells containing Atg5-myc were grown to log phase or starved for 4h and samples were prepared by TCA precipitation. Conjugation of Atg5 to Atg12 was monitored by anti-myc Western blotting. (f) Endogenously tagged Atg9-TAP wild-type (wt), 6A, 6D, atg9Δ or atg12Δ cells were grown to log phase and starved for 4h, and samples were prepared by TCA precipitation. Lipidation of Atg8 was analyzed on a 15% SDS-PAGE containing 6M urea by anti-Atg8 Western blotting. In vitro phosphorylation reactions were performed using immunopurified soluble active Atg1 against synthesized candidate peptides. Reactions were sampled at 5 minutes, 30 minutes, and 60 minutes. Each time point was injected twice into the LC-MS/MS system and label-free quantification was performed on the precursor ion chromatographic traces that correlated to the identified phosphorylated peptide for each injection. Here, the masses for M, M + 1, and M + 2 are shown which represent the naturally occurring isotopic distribution of the precursors. The isotopic dot product score represents the expected distribution of isotopes (0 to 1 where 1 is the highest). All strains of S. cerevisiae S288C BY474x genetic background are derived from the diploid strain BY4743 and carry the following markers: his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 except if stated otherwise. Peptides were synthesized to cover the entire sequence of Atg9 such that each of the potentially phosphorylated residues was flanked by at least 4 amino acids on the N-or C-terminal ends. Plasmid construction. Plasmids are listed in Supplementary Table S3 .
Site-directed mutagenesis was performed by QuikChange mutagenesis (Stratagene), and verified by sequencing. ATG9 with its endogenous promoter (547 bases) was amplified from genomic DNA and ligated into the pRS416 and pRS415 vectors using BamHI and PstI restriction sites. ATG18 with its endogenous promoter (650 bases) was amplified from genomic DNA and ligated via NotI-SbfI digested PCR into NotI-PstI cut pRS315. Fusion proteins of Atg9 and Atg18 were generated by ligating PCR-amplified TAP, GFP, 3xH3-3xHA and 3xmyc-HKMT (histone lysine methyltransferase SUV39H1 containing the H320R mutation (Zuzuarregui et al., 2012) ) tags via PstI or Sbf1 and SalI to the C-terminus of the respective protein. pGEX4T1-Atg9 757-997 wild-type and 4A mutant were generated by PCR amplification of the specific region and ligation via BamHI and SmaI. The Cup1-Ape1 plasmid was generated by ligating the PCR amplified Cup1 promoter via SalI and HindIII into pRS315 and subsequently adding the PCR amplified Ape1
ORF and its terminator via HindIII and NotI.
Yeast cell extract preparation, immunoprecipitations, TEV cleavage
and the Pho8∆60 assay. Protein extraction with TCA and immunoblotting was carried out as described previously (Kijanska et al., 2010) . To solubilize Atg9, TCA samples were beaten with glass beads after resuspension in urea loading buffer (116mM TrisHCl pH 6.8, 4.9% glycerol, 7.99 M urea, 143 mM β-mercaptoethanol, 8% SDS). To prepare extract under non-denaturing conditions, cells were grown in rich or selective medium to early logarithmic phase and harvested by centrifugation. Cell extracts were prepared by freezer milling ( Fig. 1,3,4) , or by glass bead lysis (Fig. 4d ).
HA and proteinA immunoprecipitations were carried out as described previously (Kijanska et al., 2010; Kraft et al., 2012) . For GFP immunoprecipitations, GFP-Trap agarose (ChromoTek) was used. For TEV cleavage, bound protein was incubated with TEV protease in a total of two bead volumes lysis buffer containing 0.5 mM DTT for 1 h at 16ºC.
The Pho8∆60 assay was performed as described (Klionsky, 2007) . To ensure the linear range of the enzymatic reaction, the assay was performed using two different incubation times.
Purification of GST-Atg9 C-terminal fragments. Amino acids 757-997 of
Atg9 of either wild-type or the 4A mutant were cloned into pGEX4T1 resulting in N-terminal GST fusion proteins. Proteins were purified from E.coli Rosetta pLySS cells. Cells were grown at 37ºC to an OD600 of 0.8, induced with 1mM IPTG and grown for a further 5 hours. Cells were harvested and resuspended in extraction buffer (20 mM Tris HCl pH 7.5, 250 mM NaCl, 0.5 mM EDTA, 1mM PMSF, 0.05% TX-100, 100 µg/ml DNase I (Sigma), protease inhibitor cocktail (Roche)). Cells were lysed by freeze-thawing and sonication, and supernatants prepared by 10'000 x g centrifugation. The supernatant was incubated with glutathione-beads (GE Healthcare) for 1 hour. Beads were washed extensively with wash buffer (10 mM NaPi pH 7.4, 250 mM NaCl, 0.5 mM EDTA, 1mM PMSF, 0.05% TX-100, protease inhibitor cocktail (Roche)) and bound protein was analyzed by Coomassie or Ponceau staining. PIPES pH 6.8, 5mM MgCl2, "input") to preserve organelle-enclosed particles. After three 500g centrifugation steps to remove unbroken cells, the resulting total lysate ("T") was further separated into a 13,000 x g supernatant ("S") and a pellet fraction ("P"). The efficiency of fractionation and distribution of Atg9 was determined by immunoblot analysis using anti-PAP, anti-Pgk1, and anti-Pex30
antibodies. For proteinase protection assays, the 13,000 x g pellet was resuspended in osmotic lysis buffer with or without proteinase K (50 µg/ml, AppliChem) and 0.2% Triton X-100. After 30 min incubation on ice, samples were precipitated with TCA and analyzed by Western blotting with anti-Ape1
antibodies.
Kinase assays. Kinase assays were performed as described . For in vitro phosphorylation of Atg9 757-997 , GST-tagged protein was immunoprecipitated and incubated with the phosphorylation mixture containing 1 µl of soluble Atg1 kinase. After 20 minutes incubation, the Atg9 757-997 bound beads were washed three times to remove soluble Atg1 and radioactivity incorporation was assessed by phosphorimaging.
Protein localisation in yeast and quantitative live cell imaging.
Fluorescent images were recorded with an applied precision PersonalDV microscope with a 60x oil immersion objective as stacks of 0.25 µm thick slices.
Pictures from one figure panel are taken with the same imaging setup. Maximum intensity Z projections ( Fig. 4a and S3a,b), sums of 5 slices (Fig. 4c ) or single slices (Fig. 5a ,c, S4a) of these stacks are shown. The contrast was linearly adjusted for each of the pictures. In Fig. 4a the GFP channel was deconvolved. Quantification was performed on original pictures prior to deconvolution using ImageJ software.
PAS intensity: average pixel brightness of the PAS; PAS area: average size of the PAS in pixel; cell intensity: average pixel brightness of the whole cell. Giant Ape1 assays were performed as previously described (Suzuki et al., 2013) , using 3 hours of 250nM CuSO4 induction and 1 hour of 300nM rapamycin treatment.
Peptide array analysis. The consensus phosphorylation sequence for native Atg1 complex was determined by screening a positional scanning peptide library as previously described (Mok et al., 2010) . a streptavidin membrane (SAM2 biotin capture membrane, Promega), which was washed as described, dried, and exposed to a phosphor screen. Spot intensities were quantified (Quantity One software, Bio-Rad), and data from two separate runs were normalized as described, averaged, and arranged into a positionspecific scoring matrix (PSSM). Candidate Atg1 phosphorylation sites were identified by scanning the yeast proteome with the program Scansite (Obenauer et al., 2003) using the PSSM as an input. The heat map was generated with the program Maple Tree using the log-transformed PSSM.
SILAC labelling, HTBeaq tandem affinity purification and Mass spectrometric analysis. SILAC labeling, protein purification and mass spectrometric analysis is based on methods described elsewhere (Reiter et al., 2012) . Regulated protein phosphorylation events were determined as described in (Reiter et al., 2012 ) (see supplemental information) with modifications: For phospho-mapping purified proteins were digested using different proteases (5% w/w of the estimated protein amount): Trypsin (recombinant, proteomics grade, Roche) digest was performed overnight at 37°C, chymotrypsin digest (both sequencing grade, Roche) was performed at 25°C for 4 hours. MS analysis was performed using a reversed phase nano-HPLC (Ultimate 3000, Dionex, Sunnyvale CA, USA) directly coupled to an LTQ OrbitrapVelos mass spectrometer (Thermo Fisher Scientific) via a nanoelectrospray ion source (Proxeon).
A phosphosite probability (calculated using phosphoRS 2.0) of 75% or higher was considered as confidently localized. Results were divided in lists of highly confident localized and non-localized (< 75% probability) phosphorylation sites (Supplementary Table S1 ). Unphosphorylated peptides are also listed in Supplementary Table S1 . Additionally, results were also filtered at the XCorr values to an FDR of 5% on the peptide level. These data were similarly processed as described above, except that all phosphopeptide assignments were also validated manually and SILAC quantification was performed by manual peak integration of extracted ion chromatograms (LTQ-FT data).
In vitro phosphorylation and mass spectrometric identification of were subsequently reduced using 10 mM tris(2-carboxyethyl)phosphine at a final pH 7.5 for 30 min and cysteines were alkylated using freshly prepared 20 mM iodoacetamide at a final pH 7.5 for 30 minutes in the dark (reagents from SigmaAldrich). Samples were then enzymatically cleaved using 1:100 trypsin (Promega)
at 35 º C overnight. After cleavage, peptides were acidified using 50% formic acid to a final pH 2.5-2.7 and desalted using reversed-phase silica-based chromatography columns (Waters). The final elution buffer after the peptides were washed on the columns was 40% acetonitrile: 0.1% formic acid in HPLC grade water (binding buffer). PHOS-Select™ Iron Affinity Gel (Sigma-Aldrich) was used for immobilized metal affinity chromatograph (IMAC) to enrich for phosphorylated peptides at a ratio of 30 μl of beads per sample. Binding was performed for 1 hour at room temperature with slow end-over-end rotation. After phosphopeptide binding, beads were packed onto self-made StageTips as described (Villén and Gygi, 2008) and desalting and elution washing steps were performed as described. unassigned charge states were excluded from triggering MS2 events. The raw data files were converted to the mzXML format and peptides were searched using a Sorcerer server employing the SEQUEST algorithm against the Saccharomyces Genome Database (www.yeastgenome.org) containing both forward and reverse sequences used for false discovery rate determination. For in silico digestion, trypsin was used as the protease and was assumed to cleave after lysine (K) and arginine (R) unless followed by proline (P). Two missed cleavage sites and one non-tryptic terminus were allowed per peptide. The precursor ion tolerance was set to 50 parts per million (ppm), and fragment ion tolerance was set to 0.5 dalton.
The data were searched allowing phosphorylation (+79.9663 daltons) of serine, threonine, and tyrosine as a variable modification and carboxy-amidomethylation of cysteine (+57.0214 daltons) residues as a fixed modification. Additionally, the final search results were filtered above a 1% false discovery rate. Phosphorylation sites were scored using the PTMProphet algorithm available as part of the TransProteomic Pipeline 4.6.1. and scores higher than 0.7 were considered correct phosphorylation site identifications. Results were quantified on a chromatographic level using the MS1-filtering routine available in the freely available Skyline version 1.4 (Schilling et al., 2012) .
